TY  - JOUR 
AU  - Montes Martínez, Ariana María
AU  - Pérez Pampín, Eva
AU  - Navarro-Sarabia, F.
AU  - Moreira, V.
AU  - de la Serna, A. R.
AU  - Magallares, B.
AU  - Vasilopoulos, Y.
AU  - Sarafidou, T.
AU  - Fernandez-Nebro, A.
AU  - Ordonez Mdel, C.
AU  - Narvaez, J.
AU  - Canete, J. D.
AU  - Marquez, A.
AU  - Pascual-Salcedo, D.
AU  - Joven, B.
AU  - Carreira, P.
AU  - Moreno-Ramos, M. J.
AU  - Caliz, R.
AU  - Ferrer, M. A.
AU  - Garcia-Portales, R.
AU  - BLANCO GARCIA, FRANCISCO JAVIER
AU  - Magro, C.
AU  - Raya, E.
AU  - Valor, L.
AU  - Alegre-Sancho, J. J.
AU  - Balsa, A.
AU  - Martin, J.
AU  - Plant, D.
AU  - Isaacs, J.
AU  - Morgan, A. W.
AU  - Barton, A.
AU  - Wilson, A. G.
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - González Martínez-Pedrayo, Antonio
PY  - 2015
SN  - 1478-6354
UR  - http://hdl.handle.net/20.500.11940/3077
AB  - INTRODUCTION: We have hypothesized that incompatibility between the G1m genotype of the patient and the G1m1 and G1m17 allotypes carried by infliximab (INX) and adalimumab (ADM) could decrease the efficacy of these anti-tumor necrosis factor...
LA  - eng
KW  - Adalimumab
KW  - Adult
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - Base Sequence
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Immunoglobulin Allotypes
KW  - Immunoglobulin G
KW  - Male
KW  - Middle Aged
KW  - Molecular Sequence Data
KW  - Polymorphism, Single Nucleotide
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
TI  - Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study
DO  - 10.1186/s13075-015-0571-z
T2  - ARTHRITIS RESEARCH & THERAPY
M2  - 63
VL  - 17
ER  -